In postmenopausal women, SHBG appears to inhibit NAFLD-induced hepatocellular carcinoma (HCC) through regulation of estrogen activity and inhibition of lipogenesis (Lee et al., 2019). The gene discussed is SHBG; the disease is hepatocellular carcinoma.